{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:10:52Z","timestamp":1792296652912,"version":"4.4.0"},"reference-count":94,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Chosun University","award":["K206212014"],"award-info":[{"award-number":["K206212014"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>Neuroinflammation is a complex and dynamic response of the central nervous system (CNS) to injury, infection, and disease. While acute neuroinflammation plays a protective role by facilitating pathogen clearance and tissue repair, chronic and dysregulated inflammation contributes significantly to the progression of neurodegenerative disorders such as Alzheimer\u2019s disease, Parkinson\u2019s disease, and Multiple Sclerosis. This review explores the cellular and molecular mechanisms underlying neuroinflammation, focusing on the roles of microglia, astrocytes, and peripheral immune cells. Key signaling pathways, including NF-\u03baB, JAK-STAT, and the NLRP3 inflammasome, are discussed alongside emerging regulators such as non-coding RNAs, epigenetic modifications, and the gut\u2013brain axis. The therapeutic landscape is evolving, with traditional anti-inflammatory drugs like NSAIDs and corticosteroids offering limited efficacy in chronic conditions. Immunomodulators, gene and RNA-based therapeutics, and stem cell methods have all shown promise for more specific and effective interventions. Additionally, the modulation of metabolic states and gut microbiota has emerged as a novel strategy to regulate neuroinflammation. Despite significant progress, challenges remain in translating these findings into clinically viable therapies. Future studies should concentrate on integrated, interdisciplinary methods to reduce chronic neuroinflammation and slowing the progression of neurodegenerative disorders, providing opportunities for revolutionary advances in CNS therapies.<\/jats:p>","DOI":"10.3390\/cimb47010008","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T21:13:18Z","timestamp":1735247598000},"page":"8","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Mechanisms and Emerging Regulators of Neuroinflammation: Exploring New Therapeutic Strategies for Neurological Disorders"],"prefix":"10.3390","volume":"47","author":[{"given":"Mi Eun","family":"Kim","sequence":"first","affiliation":[{"name":"Immunology Research Lab & BK21-Four Educational Research Group for Age-Associated Disorder Control Technology, Department of Biological Science, Chosun University, Gwangju 61452, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1051-581X","authenticated-orcid":false,"given":"Jun Sik","family":"Lee","sequence":"additional","affiliation":[{"name":"Immunology Research Lab & BK21-Four Educational Research Group for Age-Associated Disorder Control Technology, Department of Biological Science, Chosun University, Gwangju 61452, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Adamu, A., Li, S., Gao, F., and Xue, G. (2024). The role of neuroinflammation in neurodegenerative diseases: Current understanding and future therapeutic targets. Front. Aging Neurosci., 16.","DOI":"10.3389\/fnagi.2024.1347987"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.13419","article-title":"The impact of neuroinflammation on neuronal integrity","volume":"327","author":"Tastan","year":"2024","journal-title":"Immunol. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_4","first-page":"9999146","article-title":"Neuroinflammation: An Integrating Overview of Reactive-Neuroimmune Cell Interactions in Health and Disease","volume":"2021","author":"Udovin","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Qin, J., Ma, Z., Chen, X., and Shu, S. (2023). Microglia activation in central nervous system disorders: A review of recent mechanistic investigations and development efforts. Front. Neurol., 14.","DOI":"10.3389\/fneur.2023.1103416"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: The roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: Mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"105872","DOI":"10.1016\/j.neuint.2024.105872","article-title":"Crosstalk between peripheral inflammation and brain: Focus on the responses of microglia and astrocytes to peripheral challenge","volume":"180","author":"Geloso","year":"2024","journal-title":"Neurochem. Int."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Huang, Y., Cao, Y., and Yang, J. (2024). Astrocyte-Mediated Neuroinflammation in Neurological Conditions. Biomolecules, 14.","DOI":"10.3390\/biom14101204"},{"key":"ref_10","first-page":"1003","article-title":"Neuroinflammation Induces Neurodegeneration","volume":"1","author":"Kempuraj","year":"2016","journal-title":"J. Neurol. Neurosurg. Spine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","article-title":"Microglia Function in the Central Nervous System During Health and Neurodegeneration","volume":"35","author":"Colonna","year":"2017","journal-title":"Annu. Rev. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Shao, F., Wang, X., Wu, H., Wu, Q., and Zhang, J. (2022). Microglia and Neuroinflammation: Crucial Pathological Mechanisms in Traumatic Brain Injury-Induced Neurodegeneration. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.825086"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Bhol, N.K., Bhanjadeo, M.M., Singh, A.K., Dash, U.C., Ojha, R.R., Majhi, S., Duttaroy, A.K., and Jena, A.B. (2024). The interplay between cytokines, inflammation, and antioxidants: Mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds. Biomed. Pharmacother., 178.","DOI":"10.1016\/j.biopha.2024.117177"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1007\/s00705-021-05247-z","article-title":"Pro-inflammatory CXCL-10, TNF-alpha, IL-1beta, and IL-6: Biomarkers of SARS-CoV-2 infection","volume":"166","author":"Tripathy","year":"2021","journal-title":"Arch. Virol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41392-023-01502-8","article-title":"Inflammation and aging: Signaling pathways and intervention therapies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","article-title":"NF-kappaB in biology and targeted therapy: New insights and translational implications","volume":"9","author":"Guo","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1742-2094-11-98","article-title":"Neuroinflammation and M2 microglia: The good, the bad, and the inflamed","volume":"11","author":"Cherry","year":"2014","journal-title":"J. Neuroinflam."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Deyell, J.S., Sriparna, M., Ying, M., and Mao, X. (2023). The Interplay between alpha-Synuclein and Microglia in alpha-Synucleinopathies. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032477"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.nurt.2010.05.014","article-title":"Microglial activation and chronic neurodegeneration","volume":"7","author":"Lull","year":"2010","journal-title":"Neurotherapeutics"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Miao, J., Ma, H., Yang, Y., Liao, Y., Lin, C., Zheng, J., Yu, M., and Lan, J. (2023). Microglia in Alzheimer\u2019s disease: Pathogenesis, mechanisms, and therapeutic potentials. Front. Aging Neurosci., 15.","DOI":"10.3389\/fnagi.2023.1201982"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Wendimu, M.Y., and Hooks, S.B. (2022). Microglia Phenotypes in Aging and Neurodegenerative Diseases. Cells, 11.","DOI":"10.3390\/cells11132091"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Isik, S., Yeman Kiyak, B., Akbayir, R., Seyhali, R., and Arpaci, T. (2023). Microglia Mediated Neuroinflammation in Parkinson\u2019s Disease. Cells, 12.","DOI":"10.3390\/cells12071012"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Pant, T., Uche, N., Juric, M., Zielonka, J., and Bai, X. (2024). Regulation of immunomodulatory networks by Nrf2-activation in immune cells: Redox control and therapeutic potential in inflammatory diseases. Redox Biol., 70.","DOI":"10.1016\/j.redox.2024.103077"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.it.2020.07.007","article-title":"The Role of Astrocytes in CNS Inflammation","volume":"41","author":"Giovannoni","year":"2020","journal-title":"Trends Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Stanca, S., Rossetti, M., and Bongioanni, P. (2023). Astrocytes as Neuroimmunocytes in Alzheimer\u2019s Disease: A Biochemical Tool in the Neuron-Glia Crosstalk along the Pathogenetic Pathways. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241813880"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Matejuk, A., and Ransohoff, R.M. (2020). Crosstalk Between Astrocytes and Microglia: An Overview. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.01416"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Zang, X., Chen, S., Zhu, J., Ma, J., and Zhai, Y. (2022). The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.872134"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nri2550","article-title":"Autoimmune T cell responses in the central nervous system","volume":"9","author":"Goverman","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12974-022-02408-y","article-title":"Central nervous system macrophages in progressive multiple sclerosis: Relationship to neurodegeneration and therapeutics","volume":"19","author":"Kamma","year":"2022","journal-title":"J. Neuroinflam."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"McIntyre, L.L., Greilach, S.A., Othy, S., Sears-Kraxberger, I., Wi, B., Ayala-Angulo, J., Vu, E., Pham, Q., Silva, J., and Dang, K. (2020). Regulatory T cells promote remyelination in the murine experimental autoimmune encephalomyelitis model of multiple sclerosis following human neural stem cell transplant. Neurobiol. Dis., 140.","DOI":"10.1016\/j.nbd.2020.104868"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","article-title":"Immunology of multiple sclerosis","volume":"23","author":"Sospedra","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Fornari Laurindo, L., Aparecido Dias, J., Cressoni Araujo, A., Torres Pomini, K., Machado Galhardi, C., Rucco Penteado Detregiachi, C., Santos de Argollo Haber, L., Donizeti Roque, D., Dib Bechara, M., and Vialogo Marques de Castro, M. (2023). Immunological dimensions of neuroinflammation and microglial activation: Exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1305933"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Sivamaruthi, B.S., Raghani, N., Chorawala, M., Bhattacharya, S., Prajapati, B.G., Elossaily, G.M., and Chaiyasut, C. (2023). NF-kappaB Pathway and Its Inhibitors: A Promising Frontier in the Management of Alzheimer\u2019s Disease. Biomedicines, 11.","DOI":"10.3390\/biomedicines11092587"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: From bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"176403","DOI":"10.1016\/j.ejphar.2024.176403","article-title":"Ruxolitinib attenuates microglial inflammatory response by inhibiting NF-kappaB\/MAPK signaling pathway","volume":"968","author":"Min","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Chen, Y., Ye, X., Escames, G., Lei, W., Zhang, X., Li, M., Jing, T., Yao, Y., Qiu, Z., and Wang, Z. (2023). The NLRP3 inflammasome: Contributions to inflammation-related diseases. Cell Mol. Biol. Lett., 28.","DOI":"10.1186\/s11658-023-00462-9"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Liang, T., Zhang, Y., Wu, S., Chen, Q., and Wang, L. (2022). The Role of NLRP3 Inflammasome in Alzheimer\u2019s Disease and Potential Therapeutic Targets. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.845185"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"9982954","DOI":"10.1155\/2021\/9982954","article-title":"Inflammation and Alzheimer\u2019s Disease: Mechanisms and Therapeutic Implications by Natural Products","volume":"2021","author":"Rather","year":"2021","journal-title":"Mediat. Inflamm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2147\/NDT.S75546","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"11","author":"Zhang","year":"2015","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Zingale, V.D., Gugliandolo, A., and Mazzon, E. (2021). MiR-155: An Important Regulator of Neuroinflammation. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010090"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1007\/s00018-020-03503-0","article-title":"Long non-coding RNA NEAT1-centric gene regulation","volume":"77","author":"Wang","year":"2020","journal-title":"Cell Mol. Life Sci."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Sanchez-Mut, J.V., and Graff, J. (2015). Epigenetic Alterations in Alzheimer\u2019s Disease. Front. Behav. Neurosci., 9.","DOI":"10.3389\/fnbeh.2015.00347"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2241008","DOI":"10.1080\/15592294.2023.2241008","article-title":"Histone deacetylase 3 regulates microglial function through histone deacetylation","volume":"18","author":"Meleady","year":"2023","journal-title":"Epigenetics"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Zhang, S.Y., Zhang, L.Y., Wen, R., Yang, N., and Zhang, T.N. (2024). Histone deacetylases and their inhibitors in inflammatory diseases. Biomed. Pharmacother., 179.","DOI":"10.1016\/j.biopha.2024.117295"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/1570159X13666151021111609","article-title":"Histone Deacetylase (HDAC) Inhibitors\u2014Emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration","volume":"14","author":"Ganai","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Weng, H.R., Taing, K., Chen, L., and Penney, A. (2023). EZH2 Methyltransferase Regulates Neuroinflammation and Neuropathic Pain. Cells, 12.","DOI":"10.3390\/cells12071058"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nn.4476","article-title":"Interactions between the microbiota, immune and nervous systems in health and disease","volume":"20","author":"Fung","year":"2017","journal-title":"Nat. Neurosci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson\u2019s Disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/bph.13139","article-title":"Microglial M1\/M2 polarization and metabolic states","volume":"173","author":"Orihuela","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Sangineto, M., Ciarnelli, M., Cassano, T., Radesco, A., Moola, A., Bukke, V.N., Romano, A., Villani, R., Kanwal, H., and Capitanio, N. (2023). Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer\u2019s disease. Redox Biol., 66.","DOI":"10.1016\/j.redox.2023.102846"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s40265-023-01938-w","article-title":"Alzheimer\u2019s Disease: Novel Targets and Investigational Drugs for Disease Modification","volume":"83","author":"Cummings","year":"2023","journal-title":"Drugs"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Chen, H., Feng, Z., Min, L., Deng, W., Tan, M., Hong, J., Gong, Q., Zhang, D., Liu, H., and Hou, J. (2022). Vagus Nerve Stimulation Reduces Neuroinflammation Through Microglia Polarization Regulation to Improve Functional Recovery After Spinal Cord Injury. Front. Neurosci., 16.","DOI":"10.3389\/fnins.2022.813472"},{"key":"ref_55","first-page":"19","article-title":"Are NSAIDs useful to treat Alzheimer\u2019s disease or mild cognitive impairment?","volume":"2","author":"Imbimbo","year":"2010","journal-title":"Front. Aging Neurosci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5152\/eurasianjmed.2018.0010","article-title":"Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level","volume":"50","author":"Gunaydin","year":"2018","journal-title":"Eurasian J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Reichardt, S.D., Amouret, A., Muzzi, C., Vettorazzi, S., Tuckermann, J.P., Luhder, F., and Reichardt, H.M. (2021). The Role of Glucocorticoids in Inflammatory Diseases. Cells, 10.","DOI":"10.3390\/cells10112921"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Roberti, A., Chaffey, L.E., and Greaves, D.R. (2022). NF-kappaB Signaling and Inflammation-Drug Repurposing to Treat Inflammatory Disorders?. Biology, 11.","DOI":"10.20944\/preprints202201.0303.v1"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Gonzalez Caldito, N. (2023). Role of tumor necrosis factor-alpha in the central nervous system: A focus on autoimmune disorders. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1213448"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Jung, Y.J., Tweedie, D., Scerba, M.T., and Greig, N.H. (2019). Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments. Front. Cell Dev. Biol., 7.","DOI":"10.3389\/fcell.2019.00313"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1172\/JCI90609","article-title":"CNS inflammation and neurodegeneration","volume":"127","author":"Chitnis","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"100149","DOI":"10.1016\/j.crphar.2022.100149","article-title":"Role of pro-inflammatory cytokines in Alzheimer\u2019s disease and neuroprotective effects of pegylated self-assembled nanoscaffolds","volume":"4","author":"Rani","year":"2023","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1615\/CritRevImmunol.2016015517","article-title":"Opportunities for Translation from the Bench: Therapeutic Intervention of the JAK\/STAT Pathway in Neuroinflammatory Diseases","volume":"35","author":"Liu","year":"2015","journal-title":"Crit. Rev. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41573-020-0082-8","article-title":"Kinase inhibition in autoimmunity and inflammation","volume":"20","author":"Zarrin","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Balahura Stamat, L.R., and Dinescu, S. (2024). Inhibition of NLRP3 inflammasome contributes to paclitaxel efficacy in triple negative breast cancer treatment. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-75805-3"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.4103\/1673-5374.332129","article-title":"Small interfering RNAs based therapies for intracerebral hemorrhage: Challenges and progress in drug delivery systems","volume":"17","author":"Almarghalani","year":"2022","journal-title":"Neural Regen. Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11481-019-09849-y","article-title":"Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders","volume":"14","author":"Raikwar","year":"2019","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.ymthe.2020.09.028","article-title":"CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases","volume":"29","author":"Sharma","year":"2021","journal-title":"Mol. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.neuron.2017.04.010","article-title":"Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases","volume":"94","author":"Schoch","year":"2017","journal-title":"Neuron"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-neuro-070918-050501","article-title":"Antisense Oligonucleotide Therapies for Neurodegenerative Diseases","volume":"42","author":"Bennett","year":"2019","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/s13287-022-03122-5","article-title":"Emerging role of mesenchymal stromal cells (MSCs)-derived exosome in neurodegeneration-associated conditions: A groundbreaking cell-free approach","volume":"13","author":"Yari","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Yan, L., Zheng, D., and Xu, R.H. (2018). Critical Role of Tumor Necrosis Factor Signaling in Mesenchymal Stem Cell-Based Therapy for Autoimmune and Inflammatory Diseases. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.01658"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Gugliandolo, A., Bramanti, P., and Mazzon, E. (2020). Mesenchymal Stem Cells in Multiple Sclerosis: Recent Evidence from Pre-Clinical to Clinical Studies. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228662"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12943-023-01873-0","article-title":"Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy","volume":"22","author":"Chehelgerdi","year":"2023","journal-title":"Mol. Cancer"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"114543","DOI":"10.1016\/j.expneurol.2023.114543","article-title":"Stem cells in central nervous system diseases: Promising therapeutic strategies","volume":"369","author":"Ying","year":"2023","journal-title":"Exp. Neurol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s40001-024-01987-1","article-title":"Stem cell therapies for neurological disorders: Current progress, challenges, and future perspectives","volume":"29","author":"Seyedoshohadaei","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12974-024-03296-0","article-title":"Fueling neurodegeneration: Metabolic insights into microglia functions","volume":"21","author":"Sadeghdoust","year":"2024","journal-title":"J. Neuroinflam."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"578180","DOI":"10.1016\/j.jneuroim.2023.578180","article-title":"Microglia mediated neuroinflammation in neurodegenerative diseases: A review on the cell signaling pathways involved in microglial activation","volume":"383","author":"Biswas","year":"2023","journal-title":"J. Neuroimmunol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Pathak, D., and Sriram, K. (2023). Molecular Mechanisms Underlying Neuroinflammation Elicited by Occupational Injuries and Toxicants. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032272"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1038\/s41380-023-01964-w","article-title":"Microbiota-gut-brain axis mechanisms in the complex network of bipolar disorders: Potential clinical implications and translational opportunities","volume":"28","author":"Ortega","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Ben-Azu, B., Del Re, E.C., VanderZwaag, J., Carrier, M., Keshavan, M., Khakpour, M., and Tremblay, M.E. (2023). Emerging epigenetic dynamics in gut-microglia brain axis: Experimental and clinical implications for accelerated brain aging in schizophrenia. Front. Cell Neurosci., 17.","DOI":"10.3389\/fncel.2023.1139357"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Vieira, C.P., Lelis, C.A., Ochioni, A.C., Rosario, D.K.A., Rosario, I.L.S., Vieira, I.R.S., Carvalho, A.P.A., Janeiro, J.M., da Costa, M.P., and Lima, F.R.S. (2024). Estimating the therapeutic potential of NSAIDs and linoleic acid-isomers supplementation against neuroinflammation. Biomed. Pharmacother., 177.","DOI":"10.1016\/j.biopha.2024.116884"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Bindu, S., Mazumder, S., and Bandyopadhyay, U. (2020). Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem. Pharmacol., 180.","DOI":"10.1016\/j.bcp.2020.114147"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.4103\/0976-500X.120975","article-title":"Corticosteroid-related central nervous system side effects","volume":"4","author":"Ciriaco","year":"2013","journal-title":"J. Pharmacol. Pharmacother."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/jcd.jcd_30_21","article-title":"Analgesic efficacy of corticosteroids and nonsteroidal anti-inflammatory drugs through oral route in the reduction of postendodontic pain: A systematic review","volume":"25","author":"Jose","year":"2022","journal-title":"J. Conserv. Dent."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"DosSantos, M.F., Holanda-Afonso, R.C., Lima, R.L., DaSilva, A.F., and Moura-Neto, V. (2014). The role of the blood-brain barrier in the development and treatment of migraine and other pain disorders. Front. Cell Neurosci., 8.","DOI":"10.3389\/fncel.2014.00302"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"101148","DOI":"10.1016\/j.mam.2022.101148","article-title":"RNA interference (RNAi)-based therapeutics for treatment of rare neurologic diseases","volume":"91","author":"Germain","year":"2023","journal-title":"Mol. Asp. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1007\/s00018-020-03454-6","article-title":"Mechanisms underlying the protective effects of mesenchymal stem cell-based therapy","volume":"77","author":"Fan","year":"2020","journal-title":"Cell Mol. Life Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e2062","DOI":"10.1038\/cddis.2015.327","article-title":"Mesenchymal stem cells and immunomodulation: Current status and future prospects","volume":"7","author":"Gao","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1186\/s13287-022-03054-0","article-title":"Clinical application of mesenchymal stem cell in regenerative medicine: A narrative review","volume":"13","author":"Margiana","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Kearns, R. (2024). Gut-Brain Axis and Neuroinflammation: The Role of Gut Permeability and the Kynurenine Pathway in Neurological Disorders. Cell Mol. Neurobiol., 44.","DOI":"10.1007\/s10571-024-01496-z"},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Boehme, M., Guzzetta, K.E., Wasen, C., and Cox, L.M. (2023). The gut microbiota is an emerging target for improving brain health during ageing. Gut Microbiome, 4.","DOI":"10.1017\/gmb.2022.11"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Yoshikawa, S., Taniguchi, K., Sawamura, H., Ikeda, Y., Tsuji, A., and Matsuda, S. (2022). A New Concept of Associations between Gut Microbiota, Immunity and Central Nervous System for the Innovative Treatment of Neurodegenerative Disorders. Metabolites, 12.","DOI":"10.3390\/metabo12111052"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e34092","DOI":"10.1016\/j.heliyon.2024.e34092","article-title":"Gut-brain axis: A cutting-edge approach to target neurological disorders and potential synbiotic application","volume":"10","author":"Ashique","year":"2024","journal-title":"Heliyon"}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/47\/1\/8\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T17:00:39Z","timestamp":1760115639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/47\/1\/8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["cimb47010008"],"URL":"https:\/\/doi.org\/10.3390\/cimb47010008","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,26]]}}}